1167 related articles for article (PubMed ID: 12549624)
1. Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors.
Bustuoabad OD; di Gianni PD; Franco M; Kordon EC; Vanzulli SI; Meiss RP; Grion LC; Díaz GS; Nosetto SH; Hockl P; Lombardi MG; Pasqualini CD; Ruggiero RA
Oncol Res; 2002; 13(3):147-60. PubMed ID: 12549624
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy-dependent to ovarian-independent progression in mammary tumors delineated in primary culture: changes in signal transduction, growth factor regulation, and matrix interaction.
Imagawa W; Bandyopadhyay GK; Garcia M; Matsuzawa A; Nandi S
Cancer Res; 1992 Dec; 52(23):6531-8. PubMed ID: 1330295
[TBL] [Abstract][Full Text] [Related]
3. Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins.
Lanari C; Lüthy I; Lamb CA; Fabris V; Pagano E; Helguero LA; Sanjuan N; Merani S; Molinolo AA
Cancer Res; 2001 Jan; 61(1):293-302. PubMed ID: 11196177
[TBL] [Abstract][Full Text] [Related]
4. Progression of pregnancy-dependent mouse mammary tumors after long dormancy periods. Involvement of Wnt pathway activation.
Gattelli A; Cirio MC; Quaglino A; Schere-Levy C; Martinez N; Binaghi M; Meiss RP; Castilla LH; Kordon EC
Cancer Res; 2004 Aug; 64(15):5193-9. PubMed ID: 15289324
[TBL] [Abstract][Full Text] [Related]
5. Direct inhibiting effects of [D-Trp6]gonadotropin-releasing hormone on the estrogen-sensitive progression of polyoma virus-induced mammary tumors in athymic mice.
Néri C; Blangy D; Schatz B; Drieu K; Berebbi M; Martin PM
Cancer Res; 1990 Sep; 50(18):5892-7. PubMed ID: 2168284
[TBL] [Abstract][Full Text] [Related]
6. Accelerated progression to autonomy of a pregnancy-dependent mouse mammary tumor (TPDMT-4) by hormones.
Matsuzawa A; Kaneko T; Ikeda Y
Cancer Res; 1983 May; 43(5):2283-9. PubMed ID: 6831452
[TBL] [Abstract][Full Text] [Related]
7. A spontaneous estrogen dependent, tamoxifen sensitive mouse mammary tumor: a new model system to study hormone-responsiveness in immune competent mice.
Simian M; Manzur T; Rodriguez V; de Kier Joffé EB; Klein S
Breast Cancer Res Treat; 2009 Jan; 113(1):1-8. PubMed ID: 18183485
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV
Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317
[TBL] [Abstract][Full Text] [Related]
9. Differential response of an ovarian-responsive mouse mammary tumor to androgenic and estrogenic agents.
Matsuzawa A; Ikeda Y
Cancer Res; 1983 Aug; 43(8):3680-6. PubMed ID: 6861137
[TBL] [Abstract][Full Text] [Related]
10. Hormonal control of growth and progression in tumors of Nb rats and a theory of action.
Noble RL
Cancer Res; 1977 Jan; 37(1):82-94. PubMed ID: 830424
[TBL] [Abstract][Full Text] [Related]
11. Isolation of a stromal cell line from an early passage of a mouse mammary tumor line: a model for stromal parenchymal interactions.
Lamb CA; Fabris V; Gorostiaga MA; Helguero LA; Efeyan A; Bottino MC; Simian M; Soldati R; Sanjuan N; Molinolo A; Lanari C
J Cell Physiol; 2005 Mar; 202(3):672-82. PubMed ID: 15389583
[TBL] [Abstract][Full Text] [Related]
12. Protection by grafts of embryonal rat tissues (teratomas) against induction and transplantation of malignant tumors.
Moroson H; Ioachim HL
Cancer Res; 1995 Aug; 55(16):3664-8. PubMed ID: 7627977
[TBL] [Abstract][Full Text] [Related]
13. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.
Benakanakere I; Besch-Williford C; Schnell J; Brandt S; Ellersieck MR; Molinolo A; Hyder SM
Clin Cancer Res; 2006 Jul; 12(13):4062-71. PubMed ID: 16818706
[TBL] [Abstract][Full Text] [Related]
14. Induction of endogenous mammary tumor virus expression during hormonal induction of mammary adenoacanthomas and carcinomas of BALB/c female mice.
McGrath CM; Prass WA; Maloney TM; Jones RF
J Natl Cancer Inst; 1981 Oct; 67(4):841-52. PubMed ID: 6268884
[TBL] [Abstract][Full Text] [Related]
15. Mouse mammary tumors induced by medroxyprogesterone acetate: immunohistochemistry and hormonal receptors.
Molinolo AA; Lanari C; Charreau EH; Sanjuan N; Pasqualini CD
J Natl Cancer Inst; 1987 Dec; 79(6):1341-50. PubMed ID: 2826865
[TBL] [Abstract][Full Text] [Related]
16. Influence of pituitary grafts or prolactin administrations on the hormone sensitivity of ovarian hormone-independent mouse mammary MXT tumors.
Kiss R; de Launoit Y; Danguy A; Paridaens R; Pasteels JL
Cancer Res; 1989 Jun; 49(11):2945-51. PubMed ID: 2720654
[TBL] [Abstract][Full Text] [Related]
17. Estrogen and estrogen plus progestin act directly on the mammary gland to increase proliferation in a postmenopausal mouse model.
Raafat AM; Li S; Bennett JM; Hofseth LJ; Haslam SZ
J Cell Physiol; 2001 Apr; 187(1):81-9. PubMed ID: 11241352
[TBL] [Abstract][Full Text] [Related]
18. Effect of aromatase inhibitors on growth of mammary tumors in a nude mouse model.
Yue W; Wang J; Savinov A; Brodie A
Cancer Res; 1995 Jul; 55(14):3073-7. PubMed ID: 7606729
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effect of the antiestrogen, tamoxifen, ona pregnancy-dependent mouse mammary tumor (TPDMT-4).
Matsuzawa A; Mizuno Y; Yamamoto T
Cancer Res; 1981 Jan; 41(1):316-24. PubMed ID: 7448771
[TBL] [Abstract][Full Text] [Related]
20. The effect of estrone-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors.
Janik P; Briand P; Hartmann NR
Cancer Res; 1975 Dec; 35(12):3698-704. PubMed ID: 1192428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]